Monuril 3 g (Orifarm) or. sol. (gran.) sachet Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

monuril 3 g (orifarm) or. sol. (gran.) sachet

orifarm a.s. - fosfomycin trometamol 5,631 g - eq. fosfomycin 3 g - granules for oral solution - fosfomycin

Monuril 3g granules for oral solution Malta - Englisch - Medicines Authority

monuril 3g granules for oral solution

zambon spa via lillo del duca, 10, 20091 bresso (milan), italy - fosfomycin - granules for oral solution - fosfomycin 3 g - antibacterials for systemic use

Fosfoseptic Granules for Oral Solutions 3g Malta - Englisch - Medicines Authority

fosfoseptic granules for oral solutions 3g

adipharm ead 130, simeonovsko shosse, blvd. sofia, bulgaria - fosfomycin - granules for oral solution - fosfomycin 3 g - antibacterials for systemic use

Monuril 3g Granules for Oral Solution Malta - Englisch - Medicines Authority

monuril 3g granules for oral solution

medical logistics ltd no 8, ivo muscat azzopardi street, st julians stj 1905, malta - fosfomycin - granules for oral solution - fosfomycin 3 gram(s) - antibacterials for systemic use

Monuril 3g Granules for Oral Solution Malta - Englisch - Medicines Authority

monuril 3g granules for oral solution

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - fosfomycin - granules for oral solution - fosfomycin 3 g - antibacterials for systemic use

Monuril 3g granules for oral solution Malta - Englisch - Medicines Authority

monuril 3g granules for oral solution

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - fosfomycin - granules for oral solution - fosfomycin 3 g - antibacterials for systemic use

Fosmol 3000mg granules for Oral solution Kenia - Englisch - Pharmacy and Poisons Board

fosmol 3000mg granules for oral solution

pharma bavaria international gmbh 83209 prien am chiemsee - fosfomycin trometamol - granules for oral solution - 3000mg - fosfomycin

FOMICYT 2 G. Israel - Englisch - Ministry of Health

fomicyt 2 g.

tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 2 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.

FOMICYT 4 G. Israel - Englisch - Ministry of Health

fomicyt 4 g.

tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 4 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.

FOMICYT 8 G. Israel - Englisch - Ministry of Health

fomicyt 8 g.

tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 8 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.